STOCKHOLDERS' EQUITY

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

STOCKHOLDERS' EQUITY

STOCKHOLDERS’ EQUITY

Share Repurchase Program

In August 2021, the Company announced that the Board of Directors approved the repurchase of an additional $150 million in shares of common stock over a three-year period. This authorization was an increase to the previous $100 million repurchase programs approved in November 2018, February 2017, and February 2016. The repurchase program is set to expire in August 2024. Stock repurchases under this program may be made in the open market or in private transactions at times and in amounts determined by the Company. As of March 31, 2022, $131.4 million remained available under the program.

Common and Preferred Stock

The Board of Directors has the authority to issue common and unclassed preferred stock of up to 200 million shares and 25 million shares, respectively, with par value of $0.01 per share, as well as to fix dividends, voting and conversion rights, redemption provisions, liquidation preferences, and other rights and restrictions.

Accumulated Other Comprehensive Income (Loss)

Changes in AOCI by component, net of tax, for the three months ended March 31, 2022 are summarized as follows (in thousands):

	Foreign Currency Translation		Derivative Instruments		Total
Balances at December 31, 2021	$	(1,989)	$	2,848	$	859
Net unrealized gains (losses) arising during the period(a)	243		17,555		17,798
Less: Net realized gains (losses) reclassified to net income(b)	—		3,970		3,970
Net change during the period	243		13,585		13,828
Balances at March 31, 2022	$	(1,746)	$	16,433	$	14,687

—————————

(a) Derivative instruments net of $5.9 million of tax liability for the three months ended March 31, 2022.

(b) Derivative instruments net of $1.3 million of tax liability for the three months ended March 31, 2022.

Changes in AOCI by component, net of tax, for the three months ended March 31, 2021 are summarized as follows (in thousands):

	Foreign Currency Translation		Derivative Instruments		Total
Balances at December 31, 2020	$	(2,182)	$	9,815	$	7,633
Net unrealized gains (losses) arising during the period(c)	(303)		15,305		15,002
Less: Net realized gains (losses) reclassified to net loss(d)	—		775		775
Net change during the period	(303)		14,530		14,227
Balances at March 31, 2021	$	(2,485)	$	24,345	$	21,860

—————————

(c) Derivative instruments net of $5.2 million of tax liability for the three months ended March 31, 2021.

(d) Derivative instruments net of $0.3 million of tax liability for the three months ended March 31, 2021.